Maintenance & Monitoring Care Plan: This plan is created for GGI patients who have achieved a successful recovery as a result of participation in our survivorship care plan. The plan focuses on preventing recurrence, increasing well-being, quality of life and helping reduce side effects that remain after conventional cancer treatments.
Message from Grace: “Our Maintenance & Monitoring Plan is an important & essential part of your follow-up strategy. As with our Cancer Survivorship Care Plan; regular communication with me remains your lifeline to life extension & well-being.
As well, your Maintenance & Monitoring Plan is designed to keep your cancer navigator informed & adjust or change previously prescribed complementary medicines.
Regular Follow-ups: Avoid the pitfalls of resting on your laurels. Remissions are hard earned and at this point it is easy to become complacent. Therefore it is important to stay in regular communication with your navigator. As required in your care plan we expect that you will continue to send your blood results and imaging reports and other relevant letters from specialists. As a part of ongoing monitoring, follow-up genomic tests using Cell free DNA (liquid biopsy) is recommended every 3 months.
We have been inspired by your tenacity, dedication and will to live. We look forward to assisting you throughout the coming months to maintain your gains and work to prevent recurrences. Grace and Pip – directors the Grace Gawler Institute
Regular Monitoring ofyour health reports.
Supporting further overseas treatments (when available re Covid restrictions) and ongoing referrals.
Monitoring nutritionals & diet.
Re-assessing previously prescribed botanicals or targeted supplements.
Monitoring well-being, including psychological.
Prevention – adopt risk minimisation strategies.
Where relevant; case review and liaison with international cancer experts previously involved in your case.
Exercise plans appropriate to your post cancer condition.
Emphasis on stress reduction to help you stay well.
Genomic cF DNA testing encouraged.